世界の乳房生検市場2022-2029:製品別(吸引補助生検、コア針生検、細針吸引生検)、画像誘導技術別、エンドユーザー別、地域別

【英語タイトル】Global Breast Biopsy Market Size study & Forecast, by Product (Vacuum Assisted Biopsy, Core Needle Biopsy, Fine Needle Aspiration Biopsy), by Image Guided Technology (MRI Guided Breast Biopsy, Ultrasound Guided Breast Biopsy, Mammography Guided Stereotactic Biopsy, CT Guided Biopsy), by End User (Hospitals and Clinics, Diagnostic Centers) and Regional Analysis, 2022-2029

Bizwit Research & Consultingが出版した調査資料(BZW23MR037)・商品コード:BZW23MR037
・発行会社(調査会社):Bizwit Research & Consulting
・発行日:2023年3月6日
・ページ数:約200
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥732,600見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥925,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Bizwit Research社の本調査レポートは、2021年に691.74百万ドルであった世界の乳房生検市場規模が、2022年から2029年の間に5.1%成長すると予想しています。本レポートでは、乳房生検の世界市場について調査し、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、製品別(吸引補助生検、コア針生検、細針吸引生検)分析、画像誘導技術別(MRI誘導乳房生検、超音波誘導乳房生検、マンモグラフィ誘導定位生検、CT誘導生検)分析、エンドユーザー別(病院&診療所、診断センター)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、その他)分析、競争状況、調査プロセスなどの項目を掲載しています。また、本書には、Zenalux Biomedical Inc.、F. Hoffmann-La Roche Ltd.、OncoCyte Corporation、Laboratory Corporation of America Holdings (Labcorp)、Scion Medical Technologies LLC、Planmed Oy、Aurora Imaging Technology Inc.、Carestream Health、Cardinal Health,、PerkinElmer Inc. などの企業情報が含まれています。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・リスク分析(新型コロナウイルス感染症の影響)
・世界の乳房生検市場規模:製品別
- 吸引補助生検の市場規模
- コア針生検の市場規模
- 細針吸引生検の市場規模
・世界の乳房生検市場規模:画像誘導技術別
- MRI誘導乳房生検の市場規模
- 超音波誘導乳房生検の市場規模
- マンモグラフィ誘導定位生検の市場規模
- CT誘導生検の市場規模
・世界の乳房生検市場規模:エンドユーザー別
- 病院&診療所における市場規模
- 診断センターにおける市場規模
・世界の乳房生検市場規模:地域別
- 北米の乳房生検市場規模
- ヨーロッパの乳房生検市場規模
- アジア太平洋の乳房生検市場規模
- 中南米の乳房生検市場規模
- その他地域の乳房生検市場規模
・競争状況
・調査プロセス

Global Breast Biopsy Market is valued at approximately USD 691.74 million in 2021 and is anticipated to grow with a healthy growth rate of more than 5.1 % over the forecast period 2022-2029. Breast biopsies can also be used to test for other disorders that are found during a physical examination, however, they are most frequently used to identify breast cancer. Several methods can be used to segment the Breast Biopsy market. One of the least intrusive treatments available, fine needle aspiration biopsy, leaves no scars and is frequently used for breast biopsies. To remove tissue, a needle is inserted into the dermal tissue of the breast. The alternative technique uses ultrasonic radiation to direct the biopsy. The increasing prevalence of breast cancer and the growing Geriatric Population are key factors driving the market growth.

The rising incidences of breast cancer are contributing towards the growth of the Global Breast Biopsy Market. For instance- as per Global Cancer Observatory estimates – in 2020, the total number of breast cancer cases worldwide was estimated at 2.26 million, and this number is projected to reach 2.67 million, and a further 3.03 million in 2040. Furthermore, the increasing number of geriatric individuals is another factor driving the market space. For instance – according to the World Bank Group, the world’s old population was 727 million in 2020, and it is predicted to treble over the next three decades, reaching 1.5 million in 2050. Also, the availability of advantageous reimbursement policies as well as the growing emergence of the liquid biopsy procedures. However, the high Cost of Breast Biopsy procedures coupled with the lack of availability of screening services in developing economies hinders the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Breast Biopsy Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the presence of robust healthcare infrastructure as well as increasing incidences of breast cancer in the region. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, and increasing investment in healthcare infrastructure in the region would offer lucrative growth opportunities for the market over the forecast period.

Major market player included in this report are:
Zenalux Biomedical Inc.
F. Hoffmann-La Roche Ltd.
OncoCyte Corporation
Laboratory Corporation of America Holdings (Labcorp)
Scion Medical Technologies LLC
Planmed Oy
Aurora Imaging Technology Inc.
Carestream Health
Cardinal Health,
PerkinElmer Inc.

Recent Developments in the Market:
 In March 2021, IZI Medical Products, LLC, one of the leading manufacturers of medical devices used in interventional radiology and interventional oncology procedure announced the launch of its new Quick-Core Auto Biopsy System for soft tissue biopsy.

Global Breast Biopsy Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product, Image Guided Technology, End User, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product
Vacuum Assisted Biopsy
Core Needle Biopsy
Fine Needle Aspiration Biopsy
By Image Guided Technology
MRI Guided Breast Biopsy
Ultrasound Guided Breast Biopsy
Mammography Guided Stereotactic Biopsy
CT Guided Biopsy

By End User
Hospitals And Clinics
Diagnostic Centers

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

❖ レポートの目次 ❖

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
1.2.1. Breast Biopsy Market, by Region, 2019-2029 (USD Million)
1.2.2. Breast Biopsy Market, by Product, 2019-2029 (USD Million)
1.2.3. Breast Biopsy Market, by Image Guided Technology, 2019-2029 (USD Million)
1.2.4. Breast Biopsy Market, by End User, 2019-2029 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Breast Biopsy Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Breast Biopsy Market Dynamics
3.1. Breast Biopsy Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing prevalence of breast cancer
3.1.1.2. Growing Geriatric Population
3.1.2. Market Challenges
3.1.2.1. High Cost of Breast Biopsy procedure
3.1.2.2. Lack of availability of screening services in developing economies
3.1.3. Market Opportunities
3.1.3.1. Availability of advantageous reimbursements policies
3.1.3.2. Growing emergence of liquid biopsy procedure
Chapter 4. Global Breast Biopsy Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Breast Biopsy Market, by Product
6.1. Market Snapshot
6.2. Global Breast Biopsy Market by Product, Performance – Potential Analysis
6.3. Global Breast Biopsy Market Estimates & Forecasts by Product 2019-2029 (USD Million)
6.4. Breast Biopsy Market, Sub Segment Analysis
6.4.1. Vacuum Assisted Biopsy
6.4.2. Core Needle Biopsy
6.4.3. Fine Needle Aspiration Biopsy
Chapter 7. Global Breast Biopsy Market, by Image Guided Technology
7.1. Market Snapshot
7.2. Global Breast Biopsy Market by Image Guided Technology, Performance – Potential Analysis
7.3. Global Breast Biopsy Market Estimates & Forecasts by Image Guided Technology 2019-2029 (USD Million)
7.4. Breast Biopsy Market, Sub Segment Analysis
7.4.1. MRI Guided Breast Biopsy
7.4.2. Ultrasound Guided Breast Biopsy
7.4.3. Mammography Guided Stereotactic Biopsy
7.4.4. CT Guided Biopsy
Chapter 8. Global Breast Biopsy Market, by End User
8.1. Market Snapshot
8.2. Global Breast Biopsy Market by End User, Performance – Potential Analysis
8.3. Global Breast Biopsy Market Estimates & Forecasts by End User 2019-2029 (USD Million)
8.4. Breast Biopsy Market, Sub Segment Analysis
8.4.1. Hospitals And Clinics
8.4.2. Diagnostic Centers
Chapter 9. Global Breast Biopsy Market, Regional Analysis
9.1. Breast Biopsy Market, Regional Market Snapshot
9.2. North America Breast Biopsy Market
9.2.1. U.S. Breast Biopsy Market
9.2.1.1. Product breakdown estimates & forecasts, 2019-2029
9.2.1.2. Image Guided Technology breakdown estimates & forecasts, 2019-2029
9.2.1.3. End User breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Breast Biopsy Market
9.3. Europe Breast Biopsy Market Snapshot
9.3.1. U.K. Breast Biopsy Market
9.3.2. Germany Breast Biopsy Market
9.3.3. France Breast Biopsy Market
9.3.4. Spain Breast Biopsy Market
9.3.5. Italy Breast Biopsy Market
9.3.6. Rest of Europe Breast Biopsy Market
9.4. Asia-Pacific Breast Biopsy Market Snapshot
9.4.1. China Breast Biopsy Market
9.4.2. India Breast Biopsy Market
9.4.3. Japan Breast Biopsy Market
9.4.4. Australia Breast Biopsy Market
9.4.5. South Korea Breast Biopsy Market
9.4.6. Rest of Asia Pacific Breast Biopsy Market
9.5. Latin America Breast Biopsy Market Snapshot
9.5.1. Brazil Breast Biopsy Market
9.5.2. Mexico Breast Biopsy Market
9.5.3. Rest of Latin America Breast Biopsy Market
9.6. Rest of The World Breast Biopsy Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Zenalux Biomedical Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. F. Hoffmann-La Roche Ltd.
10.2.3. OncoCyte Corporation
10.2.4. Laboratory Corporation of America Holdings (Labcorp)
10.2.5. Scion Medical Technologies LLC
10.2.6. Planmed Oy
10.2.7. Aurora Imaging Technology Inc.
10.2.8. Carestream Health
10.2.9. Cardinal Health,
10.2.10. PerkinElmer Inc.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption



★調査レポート[世界の乳房生検市場2022-2029:製品別(吸引補助生検、コア針生検、細針吸引生検)、画像誘導技術別、エンドユーザー別、地域別] (コード:BZW23MR037)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の乳房生検市場2022-2029:製品別(吸引補助生検、コア針生検、細針吸引生検)、画像誘導技術別、エンドユーザー別、地域別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆